Inventor · disambiguated record
Nicolas Pottier
Also filed as: POTTIER NICOLAS
7 granted patents·3 pending applications·134 citations·filing 2006–2023
85Inventor score
Files withCENTRE NAT RECH SCIENT3AMAZON COM INC2POTTIER NICOLAS2INST NAT SANTE RECH MED1KELLER THOMAS L1
Top patents by PatentIndex Score
10 records- 0195US7428496B1Creating an incentive to author useful item reviewsAMAZON COM INC·Filed 2006·Granted Sep 23, 2008·73 cites·21 claims
- 0291US8140380B2Creating an incentive to author useful item reviewsKELLER THOMAS L·Filed 2010·Granted Mar 20, 2012·18 cites·24 claims
- 0390US7672868B1Creating an incentive to author useful item reviewsAMAZON COM INC·Filed 2008·Granted Mar 2, 2010·25 cites·27 claims
- 0481US8280781B1Automatically purchasing a gift from a wishlistPOTTIER NICOLAS·Filed 2008·Granted Oct 2, 2012·13 cites·45 claims
- 0574US8738460B2Automatically purchasing a gift from a wish listPOTTIER NICOLAS·Filed 2012·Granted May 27, 2014·2 cites·18 claims
- 0660US7979461B2Extended index searchingMEDIO SYSTEMS INC·Filed 2007·Granted Jul 12, 2011·3 cites·15 claims
- 0758US2025161312A1A method for the treatment of chemotherapeutic drug-induced nephrotoxicityINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0845US10647984B2Use of miR-199a-5p, targets and/or inhibitors thereof for the diagnosis, prognosis and treatment of fibroproliferative disordersCENTRE NAT RECH SCIENT·Filed 2017·Granted May 12, 2020·0 cites·5 claims
- 0942US2015045247A1USE OF miR-199a-5p, TARGETS AND/OR INHIBITORS THEREOF FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF FIBROPROLIFERATIVE DISORDERSCENTRE NAT RECH SCIENT·Filed 2013·Application pending·0 cites
- 1037US2022389420A1Agents for the treatment of patients with nsclc and methods to predict responseCENTRE NAT RECH SCIENT·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →